Prehospital Whole Blood Shows No Survival Benefit Over Component Therapy

Uncontrolled hemorrhage remains the leading preventable cause of death among trauma patients, with up to half of these fatalities occurring before the patient ever reaches a hospital [1]. Resuscitation for hemorrhagic shock has increasingly shifted toward prehospital whole blood transfusion, driven by military experience and civilian meta-analyses showing that whole blood reduces 24-hour mortality by an absolute risk reduction of 4.6 percentage points compared to standard component therapy [2, 3, 4]. Despite this enthusiasm for early whole blood administration, high-quality randomized data comparing it directly to standard component therapy in the prehospital setting have remained scarce. A newly published randomized trial now offers fresh insights into whether administering whole blood before hospital arrival truly provides a survival advantage for patients with major traumatic hemorrhage [5].